Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001596770-17-000006
Filing Date
2017-03-07
Accepted
2017-03-07 13:13:54
Documents
3

Document Format Files

Seq Description Document Type Size
1 MIRAGEN SCHEDULE 13DA 3-6-17 miragenschedule13da.htm SC 13D/A 152609
2 JOINT FILING AGREEMENT exhibit99_1.htm EX-99.1 6014
3 LOCK UP AGREEMENT lockupagreement.htm EX-99.2 21559
  Complete submission text file 0001596770-17-000006.txt   181890
Mailing Address 1941 PEARL STREET, SUITE 300 BOULDER CO 80302
Business Address 1941 PEARL STREET, SUITE 300 BOULDER CO 80302 303-444-6950
Boulder Ventures V, L.P. (Filed by) CIK: 0001554282 (see all company filings)

EIN.: 010893942 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Subject) CIK: 0001590750 (see all company filings)

EIN.: 471187261 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88625 | Film No.: 17671273
SIC: 8071 Services-Medical Laboratories